Clinical

Dataset Information

0

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment


ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of azacitidine plus phenylbutyrate in treating patients with advanced or metastatic solid tumors that have not responded to previous treatment.

DISEASE(S): Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Intestinal Neoplasms,Unspecified Adult Solid Tumor, Protocol Specific

PROVIDER: 2004726 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2087731 | ecrin-mdr-crc
| 2004721 | ecrin-mdr-crc
| 2075376 | ecrin-mdr-crc
| 2002811 | ecrin-mdr-crc
| 2005173 | ecrin-mdr-crc
| 2003342 | ecrin-mdr-crc
| 2002957 | ecrin-mdr-crc
2016-03-30 | E-GEOD-66732 | biostudies-arrayexpress
| 2004126 | ecrin-mdr-crc
| 2004140 | ecrin-mdr-crc